Tag Archives: European Medicines Agency
COVID-19, due process and an SNR problem
At a press conference streamed live on March 18, the head of the European Medicines Agency (EMA) announced that the body – which serves as the European Union’s drug and vaccine regulator – had concluded that the AstraZeneca COVID-19 vaccine was not … Continue reading
Posted in Scicomm
Tagged adverse events following immunization, AstraZeneca, COVID-19 pandemic, COVID-19 vaccines, Covishield, European Medicines Agency, mRNA vaccines, Omelas, public health, risk communication, signal-to-noise ratio, T Jacob John, Ursula Le Guin
Comments Off on COVID-19, due process and an SNR problem